Global Meningococcal Conjugate Market Size, Status and Forecast 2021-2027

菌結合型髄膜炎の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Meningococcal Conjugate Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR3700
◆調査・発行会社:QYResearch
◆発行日:2021年4月
◆ページ数:99
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、主要地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥429,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥643,500見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥858,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、菌結合型髄膜炎の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(Menactra、Menveo、NeisVac-C、Nimenrix、その他)、用途別市場規模(子供、青年・少女、大人)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・菌結合型髄膜炎の市場動向
・企業の競争状況、市場シェア
・菌結合型髄膜炎の種類別市場規模(Menactra、Menveo、NeisVac-C、Nimenrix、その他)
・菌結合型髄膜炎の用途別市場規模(子供、青年・少女、大人)
・菌結合型髄膜炎の北米市場規模2016-2027(アメリカ、カナダ)
・菌結合型髄膜炎の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・菌結合型髄膜炎のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・菌結合型髄膜炎の中南米市場規模2016-2027(メキシコ、ブラジル)
・菌結合型髄膜炎の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Sanofi Pasteur、Pfizer、Glaxo Smith Kline、Hualan Biological Engineering、JN International Medical Corporation、Baxter International、Merck、Serum Institute of India、Biomed、Novartis)
・結論

Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It’s a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease.

Market Analysis and Insights: Global Meningococcal Conjugate Market
The global Meningococcal Conjugate market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Meningococcal Conjugate market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Meningococcal Conjugate market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Meningococcal Conjugate market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Meningococcal Conjugate market.

Global Meningococcal Conjugate Scope and Market Size
Meningococcal Conjugate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Meningococcal Conjugate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Menactra
Menveo
NeisVac-C
Nimenrix
Others

Segment by Application
Children
Preteens or Teens
Adults

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sanofi Pasteur
Pfizer
Glaxo Smith Kline
Hualan Biological Engineering
JN International Medical Corporation
Baxter International
Merck
Serum Institute of India
Biomed

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Meningococcal Conjugate Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Menactra
1.2.3 Menveo
1.2.4 NeisVac-C
1.2.5 Nimenrix
1.2.6 Others
1.3 Market by Application
1.3.1 Global Meningococcal Conjugate Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Children
1.3.3 Preteens or Teens
1.3.4 Adults
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Meningococcal Conjugate Market Perspective (2016-2027)
2.2 Meningococcal Conjugate Growth Trends by Regions
2.2.1 Meningococcal Conjugate Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Meningococcal Conjugate Historic Market Share by Regions (2016-2021)
2.2.3 Meningococcal Conjugate Forecasted Market Size by Regions (2022-2027)
2.3 Meningococcal Conjugate Industry Dynamic
2.3.1 Meningococcal Conjugate Market Trends
2.3.2 Meningococcal Conjugate Market Drivers
2.3.3 Meningococcal Conjugate Market Challenges
2.3.4 Meningococcal Conjugate Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Meningococcal Conjugate Players by Revenue
3.1.1 Global Top Meningococcal Conjugate Players by Revenue (2016-2021)
3.1.2 Global Meningococcal Conjugate Revenue Market Share by Players (2016-2021)
3.2 Global Meningococcal Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Meningococcal Conjugate Revenue
3.4 Global Meningococcal Conjugate Market Concentration Ratio
3.4.1 Global Meningococcal Conjugate Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Meningococcal Conjugate Revenue in 2020
3.5 Meningococcal Conjugate Key Players Head office and Area Served
3.6 Key Players Meningococcal Conjugate Product Solution and Service
3.7 Date of Enter into Meningococcal Conjugate Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Meningococcal Conjugate Breakdown Data by Type
4.1 Global Meningococcal Conjugate Historic Market Size by Type (2016-2021)
4.2 Global Meningococcal Conjugate Forecasted Market Size by Type (2022-2027)

5 Meningococcal Conjugate Breakdown Data by Application
5.1 Global Meningococcal Conjugate Historic Market Size by Application (2016-2021)
5.2 Global Meningococcal Conjugate Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Meningococcal Conjugate Market Size (2016-2027)
6.2 North America Meningococcal Conjugate Market Size by Type
6.2.1 North America Meningococcal Conjugate Market Size by Type (2016-2021)
6.2.2 North America Meningococcal Conjugate Market Size by Type (2022-2027)
6.2.3 North America Meningococcal Conjugate Market Size by Type (2016-2027)
6.3 North America Meningococcal Conjugate Market Size by Application
6.3.1 North America Meningococcal Conjugate Market Size by Application (2016-2021)
6.3.2 North America Meningococcal Conjugate Market Size by Application (2022-2027)
6.3.3 North America Meningococcal Conjugate Market Size by Application (2016-2027)
6.4 North America Meningococcal Conjugate Market Size by Country
6.4.1 North America Meningococcal Conjugate Market Size by Country (2016-2021)
6.4.2 North America Meningococcal Conjugate Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Meningococcal Conjugate Market Size (2016-2027)
7.2 Europe Meningococcal Conjugate Market Size by Type
7.2.1 Europe Meningococcal Conjugate Market Size by Type (2016-2021)
7.2.2 Europe Meningococcal Conjugate Market Size by Type (2022-2027)
7.2.3 Europe Meningococcal Conjugate Market Size by Type (2016-2027)
7.3 Europe Meningococcal Conjugate Market Size by Application
7.3.1 Europe Meningococcal Conjugate Market Size by Application (2016-2021)
7.3.2 Europe Meningococcal Conjugate Market Size by Application (2022-2027)
7.3.3 Europe Meningococcal Conjugate Market Size by Application (2016-2027)
7.4 Europe Meningococcal Conjugate Market Size by Country
7.4.1 Europe Meningococcal Conjugate Market Size by Country (2016-2021)
7.4.2 Europe Meningococcal Conjugate Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Meningococcal Conjugate Market Size (2016-2027)
8.2 Asia-Pacific Meningococcal Conjugate Market Size by Type
8.2.1 Asia-Pacific Meningococcal Conjugate Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Meningococcal Conjugate Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Meningococcal Conjugate Market Size by Type (2016-2027)
8.3 Asia-Pacific Meningococcal Conjugate Market Size by Application
8.3.1 Asia-Pacific Meningococcal Conjugate Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Meningococcal Conjugate Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Meningococcal Conjugate Market Size by Application (2016-2027)
8.4 Asia-Pacific Meningococcal Conjugate Market Size by Region
8.4.1 Asia-Pacific Meningococcal Conjugate Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Meningococcal Conjugate Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Meningococcal Conjugate Market Size (2016-2027)
9.2 Latin America Meningococcal Conjugate Market Size by Type
9.2.1 Latin America Meningococcal Conjugate Market Size by Type (2016-2021)
9.2.2 Latin America Meningococcal Conjugate Market Size by Type (2022-2027)
9.2.3 Latin America Meningococcal Conjugate Market Size by Type (2016-2027)
9.3 Latin America Meningococcal Conjugate Market Size by Application
9.3.1 Latin America Meningococcal Conjugate Market Size by Application (2016-2021)
9.3.2 Latin America Meningococcal Conjugate Market Size by Application (2022-2027)
9.3.3 Latin America Meningococcal Conjugate Market Size by Application (2016-2027)
9.4 Latin America Meningococcal Conjugate Market Size by Country
9.4.1 Latin America Meningococcal Conjugate Market Size by Country (2016-2021)
9.4.2 Latin America Meningococcal Conjugate Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Meningococcal Conjugate Market Size (2016-2027)
10.2 Middle East & Africa Meningococcal Conjugate Market Size by Type
10.2.1 Middle East & Africa Meningococcal Conjugate Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Meningococcal Conjugate Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Meningococcal Conjugate Market Size by Type (2016-2027)
10.3 Middle East & Africa Meningococcal Conjugate Market Size by Application
10.3.1 Middle East & Africa Meningococcal Conjugate Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Meningococcal Conjugate Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Meningococcal Conjugate Market Size by Application (2016-2027)
10.4 Middle East & Africa Meningococcal Conjugate Market Size by Country
10.4.1 Middle East & Africa Meningococcal Conjugate Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Meningococcal Conjugate Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Company Details
11.1.2 Sanofi Pasteur Business Overview
11.1.3 Sanofi Pasteur Meningococcal Conjugate Introduction
11.1.4 Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2016-2021)
11.1.5 Sanofi Pasteur Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Meningococcal Conjugate Introduction
11.2.4 Pfizer Revenue in Meningococcal Conjugate Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Glaxo Smith Kline
11.3.1 Glaxo Smith Kline Company Details
11.3.2 Glaxo Smith Kline Business Overview
11.3.3 Glaxo Smith Kline Meningococcal Conjugate Introduction
11.3.4 Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2016-2021)
11.3.5 Glaxo Smith Kline Recent Development
11.4 Hualan Biological Engineering
11.4.1 Hualan Biological Engineering Company Details
11.4.2 Hualan Biological Engineering Business Overview
11.4.3 Hualan Biological Engineering Meningococcal Conjugate Introduction
11.4.4 Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2016-2021)
11.4.5 Hualan Biological Engineering Recent Development
11.5 JN International Medical Corporation
11.5.1 JN International Medical Corporation Company Details
11.5.2 JN International Medical Corporation Business Overview
11.5.3 JN International Medical Corporation Meningococcal Conjugate Introduction
11.5.4 JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2016-2021)
11.5.5 JN International Medical Corporation Recent Development
11.6 Baxter International
11.6.1 Baxter International Company Details
11.6.2 Baxter International Business Overview
11.6.3 Baxter International Meningococcal Conjugate Introduction
11.6.4 Baxter International Revenue in Meningococcal Conjugate Business (2016-2021)
11.6.5 Baxter International Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Meningococcal Conjugate Introduction
11.7.4 Merck Revenue in Meningococcal Conjugate Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Serum Institute of India
11.8.1 Serum Institute of India Company Details
11.8.2 Serum Institute of India Business Overview
11.8.3 Serum Institute of India Meningococcal Conjugate Introduction
11.8.4 Serum Institute of India Revenue in Meningococcal Conjugate Business (2016-2021)
11.8.5 Serum Institute of India Recent Development
11.9 Biomed
11.9.1 Biomed Company Details
11.9.2 Biomed Business Overview
11.9.3 Biomed Meningococcal Conjugate Introduction
11.9.4 Biomed Revenue in Meningococcal Conjugate Business (2016-2021)
11.9.5 Biomed Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Meningococcal Conjugate Introduction
11.10.4 Novartis Revenue in Meningococcal Conjugate Business (2016-2021)
11.10.5 Novartis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Meningococcal Conjugate Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Menactra
Table 3. Key Players of Menveo
Table 4. Key Players of NeisVac-C
Table 5. Key Players of Nimenrix
Table 6. Key Players of Others
Table 7. Global Meningococcal Conjugate Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Meningococcal Conjugate Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Meningococcal Conjugate Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Meningococcal Conjugate Market Share by Regions (2016-2021)
Table 11. Global Meningococcal Conjugate Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Meningococcal Conjugate Market Share by Regions (2022-2027)
Table 13. Meningococcal Conjugate Market Trends
Table 14. Meningococcal Conjugate Market Drivers
Table 15. Meningococcal Conjugate Market Challenges
Table 16. Meningococcal Conjugate Market Restraints
Table 17. Global Meningococcal Conjugate Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Meningococcal Conjugate Market Share by Players (2016-2021)
Table 19. Global Top Meningococcal Conjugate Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Conjugate as of 2020)
Table 20. Ranking of Global Top Meningococcal Conjugate Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Meningococcal Conjugate Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Meningococcal Conjugate Product Solution and Service
Table 24. Date of Enter into Meningococcal Conjugate Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Meningococcal Conjugate Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Meningococcal Conjugate Revenue Market Share by Type (2016-2021)
Table 28. Global Meningococcal Conjugate Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Meningococcal Conjugate Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Meningococcal Conjugate Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Meningococcal Conjugate Revenue Market Share by Application (2016-2021)
Table 32. Global Meningococcal Conjugate Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Meningococcal Conjugate Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Meningococcal Conjugate Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Meningococcal Conjugate Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Meningococcal Conjugate Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Meningococcal Conjugate Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Meningococcal Conjugate Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Meningococcal Conjugate Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Meningococcal Conjugate Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Meningococcal Conjugate Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Meningococcal Conjugate Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Meningococcal Conjugate Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Meningococcal Conjugate Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Meningococcal Conjugate Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Meningococcal Conjugate Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Meningococcal Conjugate Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Meningococcal Conjugate Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Meningococcal Conjugate Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Meningococcal Conjugate Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Meningococcal Conjugate Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Meningococcal Conjugate Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Meningococcal Conjugate Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Meningococcal Conjugate Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Meningococcal Conjugate Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Meningococcal Conjugate Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Meningococcal Conjugate Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Meningococcal Conjugate Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Meningococcal Conjugate Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Meningococcal Conjugate Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Meningococcal Conjugate Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Meningococcal Conjugate Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Meningococcal Conjugate Market Size by Country (2022-2027) & (US$ Million)
Table 64. Sanofi Pasteur Company Details
Table 65. Sanofi Pasteur Business Overview
Table 66. Sanofi Pasteur Meningococcal Conjugate Product
Table 67. Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 68. Sanofi Pasteur Recent Development
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Meningococcal Conjugate Product
Table 72. Pfizer Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. Glaxo Smith Kline Company Details
Table 75. Glaxo Smith Kline Business Overview
Table 76. Glaxo Smith Kline Meningococcal Conjugate Product
Table 77. Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 78. Glaxo Smith Kline Recent Development
Table 79. Hualan Biological Engineering Company Details
Table 80. Hualan Biological Engineering Business Overview
Table 81. Hualan Biological Engineering Meningococcal Conjugate Product
Table 82. Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 83. Hualan Biological Engineering Recent Development
Table 84. JN International Medical Corporation Company Details
Table 85. JN International Medical Corporation Business Overview
Table 86. JN International Medical Corporation Meningococcal Conjugate Product
Table 87. JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 88. JN International Medical Corporation Recent Development
Table 89. Baxter International Company Details
Table 90. Baxter International Business Overview
Table 91. Baxter International Meningococcal Conjugate Product
Table 92. Baxter International Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 93. Baxter International Recent Development
Table 94. Merck Company Details
Table 95. Merck Business Overview
Table 96. Merck Meningococcal Conjugate Product
Table 97. Merck Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 98. Merck Recent Development
Table 99. Serum Institute of India Company Details
Table 100. Serum Institute of India Business Overview
Table 101. Serum Institute of India Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 102. Serum Institute of India Recent Development
Table 103. Biomed Company Details
Table 104. Biomed Business Overview
Table 105. Biomed Meningococcal Conjugate Product
Table 106. Biomed Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 107. Biomed Recent Development
Table 108. Novartis Company Details
Table 109. Novartis Business Overview
Table 110. Novartis Meningococcal Conjugate Product
Table 111. Novartis Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 112. Novartis Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Meningococcal Conjugate Market Share by Type: 2020 VS 2027
Figure 2. Menactra Features
Figure 3. Menveo Features
Figure 4. NeisVac-C Features
Figure 5. Nimenrix Features
Figure 6. Others Features
Figure 7. Global Meningococcal Conjugate Market Share by Application: 2020 VS 2027
Figure 8. Children Case Studies
Figure 9. Preteens or Teens Case Studies
Figure 10. Adults Case Studies
Figure 11. Meningococcal Conjugate Report Years Considered
Figure 12. Global Meningococcal Conjugate Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Meningococcal Conjugate Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Meningococcal Conjugate Market Share by Regions: 2020 VS 2027
Figure 15. Global Meningococcal Conjugate Market Share by Regions (2022-2027)
Figure 16. Global Meningococcal Conjugate Market Share by Players in 2020
Figure 17. Global Top Meningococcal Conjugate Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Conjugate as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Meningococcal Conjugate Revenue in 2020
Figure 19. Global Meningococcal Conjugate Revenue Market Share by Type (2016-2021)
Figure 20. Global Meningococcal Conjugate Revenue Market Share by Type (2022-2027)
Figure 21. North America Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Meningococcal Conjugate Market Share by Type (2016-2027)
Figure 23. North America Meningococcal Conjugate Market Share by Application (2016-2027)
Figure 24. North America Meningococcal Conjugate Market Share by Country (2016-2027)
Figure 25. United States Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Meningococcal Conjugate Market Share by Type (2016-2027)
Figure 29. Europe Meningococcal Conjugate Market Share by Application (2016-2027)
Figure 30. Europe Meningococcal Conjugate Market Share by Country (2016-2027)
Figure 31. Germany Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Meningococcal Conjugate Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Meningococcal Conjugate Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Meningococcal Conjugate Market Share by Region (2016-2027)
Figure 41. China Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Meningococcal Conjugate Market Share by Type (2016-2027)
Figure 49. Latin America Meningococcal Conjugate Market Share by Application (2016-2027)
Figure 50. Latin America Meningococcal Conjugate Market Share by Country (2016-2027)
Figure 51. Mexico Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Meningococcal Conjugate Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Meningococcal Conjugate Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Meningococcal Conjugate Market Share by Country (2016-2027)
Figure 57. Turkey Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Sanofi Pasteur Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 62. Glaxo Smith Kline Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 63. Hualan Biological Engineering Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 64. JN International Medical Corporation Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 65. Baxter International Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 67. Serum Institute of India Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 68. Biomed Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 69. Novartis Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[菌結合型髄膜炎の世界市場規模・現状・予測2021年-2027年] (Global Meningococcal Conjugate Market Size, Status and Forecast 2021-2027 / QY21APR3700)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆